ARX, InnovoCommerce partner

Tuesday, March 29, 2011 11:37 AM

ARX, a provider of digital signature solutions, has partnered with InnovoCommerce, an independent software vendor.

InnovoCommerce helps solve complex governance, risk management and compliance business challenges using the Microsoft technology platform with a core focus on Microsoft SharePoint. InnovoCommerce is the developer of innovoPOINT, a clinical and investigator portal solution.

InnovoCommerce now offers the CoSign digital signature solution as part of its two core offerings, the innovoPOINT Clinical investigator portal, and innovoPOINT DM, a document management solution for life science organizations. CoSign can be used in FDA Title 21 CFR part 11 compliant processes by pharmaceutical and biotechnology companies for signing SOPs, quality and compliance documentation, research and development documentation, corporate compliance documents, and more. InnovoPOINT Clinical customers can also use CoSign for obtaining signatures from external parties, such as clinical trial investigators.

CoSign is also being used within InnovoCommerce as part of the in-house innovoPOINT DM deployment. Employees use the integrated solution to digitally sign PDF files that have been converted from Word, including SOPs and quality documents. 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs